Not Yet Recruiting
Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications
NCT06121271
- Conditions
- Adenocarcinoma, Bronchial and Thymic Neuroendocrine Tumour, Carcinoma, +13 more
- Locations
-
Not specified